Healios K.K. (4593.T)
JPY 181.0
(1.69%)
JPY 181.0
(1.69%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 121 Million JPY | 34.44% |
| 2022 | 90 Million JPY | 119.51% |
| 2021 | 41 Million JPY | 51.85% |
| 2020 | 27 Million JPY | -69.66% |
| 2019 | 89 Million JPY | 0.0% |
| 2018 | - JPY | -100.0% |
| 2017 | 27.66 Million JPY | -64.37% |
| 2016 | 77.64 Million JPY | -20.91% |
| 2015 | 98.16 Million JPY | -64.94% |
| 2014 | 279.99 Million JPY | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 498 Million JPY | 4880.0% |
| 2024 Q1 | 10 Million JPY | 42.86% |
| 2023 Q4 | 7 Million JPY | 0.0% |
| 2023 FY | 121 Million JPY | 34.44% |
| 2023 Q2 | 100 Million JPY | 1328.57% |
| 2023 Q1 | 7 Million JPY | -88.33% |
| 2023 Q3 | 7 Million JPY | -93.0% |
| 2022 Q1 | 11 Million JPY | 0.0% |
| 2022 Q4 | 60 Million JPY | 650.0% |
| 2022 FY | 90 Million JPY | 119.51% |
| 2022 Q3 | 8 Million JPY | -27.27% |
| 2022 Q2 | 11 Million JPY | 0.0% |
| 2021 Q3 | 11 Million JPY | 10.0% |
| 2021 FY | 41 Million JPY | 51.85% |
| 2021 Q1 | 9 Million JPY | 50.0% |
| 2021 Q2 | 10 Million JPY | 11.11% |
| 2021 Q4 | 11 Million JPY | 0.0% |
| 2020 FY | 27 Million JPY | -69.66% |
| 2020 Q4 | 6 Million JPY | -14.29% |
| 2020 Q3 | 7 Million JPY | 0.0% |
| 2020 Q2 | 7 Million JPY | 0.0% |
| 2020 Q1 | 7 Million JPY | 0.0% |
| 2019 FY | 89 Million JPY | 0.0% |
| 2019 Q2 | -34 Million JPY | 0.0% |
| 2019 Q1 | - JPY | 0.0% |
| 2019 Q3 | 7 Million JPY | 120.59% |
| 2019 Q4 | - JPY | -100.0% |
| 2018 Q4 | - JPY | 0.0% |
| 2018 FY | - JPY | -100.0% |
| 2018 Q2 | - JPY | 0.0% |
| 2018 Q1 | - JPY | 0.0% |
| 2018 Q3 | - JPY | 0.0% |
| 2017 Q1 | 20.96 Million JPY | 5.21% |
| 2017 Q4 | - JPY | 0.0% |
| 2017 Q2 | 6.7 Million JPY | -68.04% |
| 2017 Q3 | - JPY | -100.0% |
| 2017 FY | 27.66 Million JPY | -64.37% |
| 2016 Q1 | 20.66 Million JPY | -5.36% |
| 2016 FY | 77.64 Million JPY | -20.91% |
| 2016 Q4 | 19.92 Million JPY | 25.73% |
| 2016 Q3 | 15.84 Million JPY | -25.26% |
| 2016 Q2 | 21.2 Million JPY | 2.61% |
| 2015 Q4 | 21.83 Million JPY | 26.91% |
| 2015 Q1 | 19.88 Million JPY | 0.0% |
| 2015 Q2 | 39.24 Million JPY | 97.38% |
| 2015 Q3 | 17.2 Million JPY | -56.16% |
| 2015 FY | 98.16 Million JPY | -64.94% |
| 2014 FY | 279.99 Million JPY | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 4.77 Billion JPY | 97.463% |
| PRISM BioLab Co.,LTD | 112.92 Million JPY | -7.15% |
| GNI Group Ltd. | 26.01 Billion JPY | 99.535% |
| Linical Co., Ltd. | 12.3 Billion JPY | 99.017% |
| Trans Genic Inc. | 13.08 Billion JPY | 99.075% |
| MEDINET Co., Ltd. | 661.54 Million JPY | 81.709% |
| Soiken Holdings Inc. | 5.15 Billion JPY | 97.654% |
| Cytori Cell Research Institute, Inc. | 1.56 Billion JPY | 92.246% |
| AnGes, Inc. | 152.98 Million JPY | 20.907% |
| OncoTherapy Science, Inc. | 610.11 Million JPY | 80.168% |
| Nxera Pharma Co., Ltd. | 12.76 Billion JPY | 99.052% |
| Immuno-Biological Laboratories Co., Ltd. | 816.7 Million JPY | 85.184% |
| NanoCarrier Co., Ltd. | 135.5 Million JPY | 10.706% |
| Carna Biosciences, Inc. | 1.62 Billion JPY | 92.558% |
| CanBas Co., Ltd. | - JPY | -Infinity% |
| D. Western Therapeutics Institute, Inc. | 428.36 Million JPY | 71.753% |
| RaQualia Pharma Inc. | 1.9 Billion JPY | 93.636% |
| Chiome Bioscience Inc. | 682.46 Million JPY | 82.27% |
| Kidswell Bio Corporation | 2.43 Billion JPY | 95.023% |
| PeptiDream Inc. | 28.71 Billion JPY | 99.579% |
| Oncolys BioPharma Inc. | 63.03 Million JPY | -91.948% |
| Ribomic Inc. | - JPY | -Infinity% |
| SanBio Company Limited | - JPY | -Infinity% |
| BrightPath Biotherapeutics Co., Ltd. | 72 Thousand JPY | -167955.556% |
| Kubota Pharmaceutical Holdings Co., Ltd. | 39.88 Million JPY | -203.357% |
| Delta-Fly Pharma, Inc. | - JPY | -Infinity% |
| StemRIM | - JPY | -Infinity% |
| CellSource Co., Ltd. | 4.51 Billion JPY | 97.317% |
| FunPep Company Limited | 530 Thousand JPY | -22730.189% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -74.729% |
| Stella Pharma Corporation | 269.49 Million JPY | 55.101% |
| TMS Co., Ltd. | - JPY | -Infinity% |
| Noile-Immune Biotech Inc. | 316.81 Million JPY | 61.808% |
| Cuorips Inc. | 23.1 Million JPY | -423.764% |
| K Pharma,Inc. | 1 Billion JPY | 87.9% |
| Takara Bio Inc. | 43.5 Billion JPY | 99.722% |
| ReproCELL Incorporated | 2.42 Billion JPY | 95.014% |
| PhoenixBio Co., Ltd. | 1.71 Billion JPY | 92.946% |
| StemCell Institute Inc. | 2.48 Billion JPY | 95.123% |
| Japan Tissue Engineering Co., Ltd. | 2.51 Billion JPY | 95.187% |
| CellSeed Inc. | 190.13 Million JPY | 36.361% |